Cancer
CEA 605-613 mutant (HLA-A*02:01) 610D YLSGADLNL
Product number: EP11112_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide CEA 605-613 mutant (HLA-A*02:01) 610D with the amino acid sequence YLSGADLNL is a linear peptidic epitope (epitope ID 2218585) studied as part of Cell adhesion molecule CEACAM5 (UniProt:P06731) from Homo sapiens (human).
The epitope is an analog of: YLSGANLNL from Homo sapiens (human) Carcinoembryonic antigen-related cell adhesion molecule 5.
CEA 605-613 mutant (HLA-A*02:01) 610D has been studied for immune reactivity in publications and has been tested in T cell assays.
TechData
| Sequence: | YLSGADLNL |
| Gene: | CEACAM5 |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Carcinoembryonic antigen-related cell adhesion molecule 5 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |